about
Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literatureAcute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-upMortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort[Data on rilpivirine in treatment-naïve patients. Lessons from ECHO, THRIVE and STaR].Autoimmune neutropenia and thrombocytopenia associated with development of antibodies to human immunodeficiency virus.Adenosine deaminase activity in rheumatoid pleural effusion.Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients.Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature.Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapyLactic acidosis related to nucleoside therapy in HIV-infected patients.Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].Epidemiology of infections by HIV, Syphilis, Gonorrhea and Lymphogranuloma Venereum in Barcelona City: a population-based incidence study.Multilocus microsatellite typing of Leishmania infantum isolates in monitored Leishmania/HIV coinfected patientsRole of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?Darunavir and ritonavir total and unbound plasmatic concentrations in HIV-HCV-coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patientsTransmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment.Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patientsTropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain.Double-boosted protease inhibitor antiretroviral regimens: what role?Visceral leishmaniasis among liver transplant recipients: an overview.Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adultsTreatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational studyThe future of antiretroviral therapy: challenges and needs.From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir.Management of tuberculosis in HIV-infected patients.Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant status.Abacavir coadministration does not interfere with the suppressive activity of ribavirin in an HCV replicon system.Efficacy of recombinant interleukin-2 (rIL-2) in patients with advanced HIV-1 infection and blunted immune response to HAART.The effectiveness of electrocautery ablation for the treatment of high-grade anal intraepithelial neoplasia in HIV-infected men who have sex with men.Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary?A nested polymerase chain reaction for diagnosis and follow-up of human visceral leishmaniasis patients using blood samples.[Visceral leishmaniasis in patients with HIV infection]Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.Impact of low-level viraemia on virological failure in HIV-1-infected patients with stable antiretroviral treatment.
P50
Q28082149-FEA29539-6787-4533-AB0A-B6B921628071Q28302032-4804B65A-FAC2-4E61-97FE-4DB2FF341607Q28551895-4B53EEC5-E198-4B46-8FBA-7FCC1F421598Q30697730-891F6562-3D3A-41A8-92C0-8FBAB560BD37Q33431572-68D26A07-7E09-4833-A52E-454DC001DC9DQ33560862-C56CBB01-8FCB-40FB-A2A4-FF5219391A20Q33982131-FA1CEFFB-CC94-466D-B3D5-D41F8B4FE766Q33983443-C53C4E20-1464-4279-BA81-7B5D696110A5Q34535751-55413F36-A604-4FC8-A86F-00A2131D036FQ34612023-0C1B17ED-E945-4D47-94BF-77F75DA46D05Q35183747-4EDE6B97-1C4E-4E6B-BCE3-54ED68A84C0AQ35677256-98CE1F4D-FBD7-4B90-AAE2-D14607FC4B26Q35799788-356E1C75-1B1C-4E66-95E2-345F2ABCDA72Q35878504-E7DA14E1-F148-4017-90FF-A77AA484B08BQ35921994-FA1F1A4F-34BD-42B4-AF15-5CCB4B2B111FQ35981954-F6FC2854-9F40-4A4E-B89B-1518F5E128EFQ36158135-8B64A3A1-5300-4127-B6D3-B8D651DF213DQ36543845-1D82C5FF-4227-4933-A54F-3BE5D028928BQ36765799-4C0D3E89-E2D7-46CD-A3AE-18DECFA2A111Q37107899-9ABBE202-356E-4470-8C11-66E4090645ACQ37119579-73D968B4-C0E2-4010-BE05-18C4861E8D0BQ37313399-29B608F8-31E7-4311-8878-58A146CC0BA7Q37331906-826C6855-F5B9-437B-AF9B-69E965A867F9Q37598597-C8B00CC0-233F-49E0-857A-36D0DEB61441Q37661017-996AEB10-0F9C-4405-BFE4-78D0E0E15BA5Q37708892-877BC372-2FF5-426C-A0C4-B3ABF45B8359Q37828539-7DC018C1-ADFC-4BB5-A52B-83823C723B30Q38069084-777DB9C1-E362-4B51-9F30-0A5C2F92A51CQ38225483-D8B6D19B-69F1-4500-9A82-0B1F01EA3162Q38505953-4C21A5E3-FE70-4EFC-AE62-BC62D9AFD967Q39372763-3787B22C-5A27-4FD4-AFEF-740D2886B5E7Q39477718-D66899C3-C5F9-48DE-B52A-6D3FAF619252Q39829702-7FB1A957-48FB-43D6-824D-ADA42B8964A2Q40188071-894CB4CE-BC1E-4ACB-A4C5-B859745E67C8Q40546602-067F1B67-0857-4034-9E17-465008DDE21BQ40580869-DC1EFF12-F335-4174-8DFD-73F53EB511F2Q40689401-445D8E2A-AF81-4C60-B35F-A9B40C99B853Q40723867-7F9253E3-1C06-4147-AFF6-B112B60C3D73Q40755766-FDBED662-E667-44B2-9B9C-67F21C56FDE8Q40836654-22DCEDDB-15E6-4036-919F-B3871BB1AD8F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Esteban Ribera
@ast
Esteban Ribera
@en
Esteban Ribera
@es
Esteban Ribera
@nl
Esteban Ribera
@sl
type
label
Esteban Ribera
@ast
Esteban Ribera
@en
Esteban Ribera
@es
Esteban Ribera
@nl
Esteban Ribera
@sl
prefLabel
Esteban Ribera
@ast
Esteban Ribera
@en
Esteban Ribera
@es
Esteban Ribera
@nl
Esteban Ribera
@sl
P106
P21
P31
P496
0000-0002-3752-8808